Constitutive and inflammatory immunopeptidome of pancreatic β-cells

Diabetes

Volumn 61, Issue 11, 2012, Pages 3018-3025

  Dudek, Nadine L ^a   Tan, Chor Teck ^a   Gorasia, Dhana G ^a   Croft, Nathan P ^a   Illing, Patricia T ^b   Purcell, Anthony W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; GAMMA INTERFERON; GLUCOSE 6 PHOSPHATASE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; FEMALE; LIQUID CHROMATOGRAPHY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TANDEM MASS SPECTROMETRY; THYMUS;

ANIMALS; AUTOANTIGENS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE-6-PHOSPHATASE; HISTOCOMPATIBILITY ANTIGENS; IMMUNODOMINANT EPITOPES; INFLAMMATION MEDIATORS; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; JANUS KINASE 1; MICE; MICE, INBRED NOD; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PROTEINS; SPLEEN; TANDEM MASS SPECTROMETRY; THYMUS GLAND;

EID: 84868012446     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1333     Document Type: Article

References (28)

1. Yamanouchi J, Verdaguer J, Han B, Amrani A, Serra P, Santamaria P. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. J Immunol 2003;171:6900-6909
2. Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol 1996;157:3688-3693
3. Itoh N, Hanafusa T, Miyazaki A, et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993;92:2313-2322
4. Imagawa A, Hanafusa T, Itoh N, et al. Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus. Diabetologia 1999;42:574-578
5. Gianani R, Campbell-Thompson M, Sarkar SA, et al. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 2010;53: 690-698
6. Tan CT, Croft NP, Dudek NL, Williamson NA, Purcell AW. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 2011;11:2336-2340
7. Dudek NL, Perlmutter P, Aguilar MI, Croft NP, Purcell AW. Epitope discovery and their use in peptide based vaccines. Curr Pharm Des 2010;16: 3149-3157
8. Alleva DG, Crowe PD, Jin L, et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 2001;107:173-180
9. Hamaguchi K, Gaskins HR, Leiter EH. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 1991;40:842-849
10. Purcell AW, Gorman JJ. The use of post-source decay in matrix-assisted laser desorption/ionisation mass spectrometry to delineate T cell determinants. J Immunol Methods 2001;249:17-31
11. Shilov IV, Seymour SL, Patel AA, et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 2007;6:1638-1655
12. Bhatia VN, Perlman DH, Costello CE, McComb ME. Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal Chem 2009;81:9819-9823
13. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanović S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999;50:213-219
14. Taylor CF, Paton NW, Lilley KS, et al. The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol 2007;25:887-893
15. Mitaksov V, Fremont DH. Structural definition of the H-2Kd peptidebinding motif. J Biol Chem 2006;281:10618-10625
16. Romero P, Corradin G, Luescher IF, Maryanski JL. H-2Kd-restricted anti-genic peptides share a simple binding motif. J Exp Med 1991;174:603-612
17. Quesnel A, Casrouge A, Kourilsky P, Abastado JP, Trudelle Y. Use of synthetic peptide libraries for the H-2Kd binding motif identification. Pept Res 1995;8:44-51
18. Delgado JC, Escobar H, Crockett DK, Reyes-Vargas E, Jensen PE. Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction. Immunogenetics 2009;61:241-246
19. Gorbea C, Goellner GM, Teter K, Holmes RK, Rechsteiner M. Characterization of mammalian Ecm29, a 26 S proteasome-associated protein that localizes to the nucleus and membrane vesicles. J Biol Chem 2004;279:54849-54861
20. Gorbea C, Pratt G, Ustrell V, et al. A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components. J Biol Chem 2010;285:31616-31633
21. Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 2007;6:404-414
22. Tynan FE, Reid HH, Kjer-Nielsen L, et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol 2007;8:268-276
23. Escobar H, Crockett DK, Reyes-Vargas E, et al. Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs. J Immunol 2008;181:4874-4882
24. Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J 2001;20:2357-2366
25. Hammer GE, Gonzalez F, James E, Nolla H, Shastri N. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 2007;8:101-108
26. Suri A, Walters JJ, Rohrs HW, Gross ML, Unanue ER. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules. J Immunol 2008;180:3849-3856
27. Delong T, Baker RL, Reisdorph N, et al. Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T Cells. Diabetes 2011;60:2325-2330
28. Han B, Serra P, Amrani A, et al. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat Med 2005;11:645-652